MiR-223/PAX6 Axis Regulates Glioblastoma Stem Cell Proliferation and the Chemo Resistance to TMZ via Regulating PI3K/Akt Pathway
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-223/PAX6 Axis Regulates Glioblastoma Stem Cell Proliferation and the Chemo Resistance to TMZ via Regulating PI3K/Akt Pathway
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 118, Issue 10, Pages 3452-3461
Publisher
Wiley
Online
2017-03-24
DOI
10.1002/jcb.26003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer stem cell-vascular endothelial cell interactions in glioblastoma
- (2016) Aman Sharma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- GBM surgery in the elderly-time to be more aggressive?
- (2016) Jetan H. Badhiwala et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Targeting autophagy to sensitive glioma to temozolomide treatment
- (2016) Yuanliang Yan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
- (2016) Xiaoman Li et al. Oncotarget
- Targeting the PI3K/AKT/mTOR Signaling Pathway in Medulloblastoma
- (2015) V. Dimitrova et al. CURRENT MOLECULAR MEDICINE
- MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7
- (2015) Xiaoying Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A novel stem cell culture model of recurrent glioblastoma
- (2015) Maleeha A. Qazi et al. JOURNAL OF NEURO-ONCOLOGY
- Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma
- (2015) Amy Barone et al. Oncotarget
- microRNA Expression Pattern Modulates Temozolomide Response in GBM Tumors with Cancer Stem Cells
- (2014) Gulcin Tezcan et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- The sensitivity of gastric cancer to trastuzumab is regulated by the miR-223/FBXW7 pathway
- (2014) Kojiro Eto et al. INTERNATIONAL JOURNAL OF CANCER
- Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?
- (2014) Dieter Lemke et al. JOURNAL OF NEUROCHEMISTRY
- A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool
- (2014) Lorea Manterola et al. NEURO-ONCOLOGY
- MiR-330-Mediated Regulation of SH3GL2 Expression Enhances Malignant Behaviors of Glioblastoma Stem Cells by Activating ERK and PI3K/AKT Signaling Pathways
- (2014) Yilong Yao et al. PLoS One
- Human Vaccines & Immunotherapeutics: News
- (2014) Eva M Riedmann Human Vaccines & Immunotherapeutics
- miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1
- (2013) Jie Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Original article CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component
- (2013) Ulf D. Kahlert et al. FOLIA NEUROPATHOLOGICA
- Mechanism of temozolomide-induced antitumour effects on glioma cells
- (2013) Wei Shen et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- The miR-223/Nuclear Factor I-A Axis Regulates Glial Precursor Proliferation and Tumorigenesis in the CNS
- (2013) S. M. Glasgow et al. JOURNAL OF NEUROSCIENCE
- MN linked to improved prognosis in anti-GBM disease
- (2013) David Holmes Nature Reviews Nephrology
- PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells
- (2009) Anne-Marie Bleau et al. Cell Stem Cell
- PAX6 suppression of glioma angiogenesis and the expression of vascular endothelial growth factor A
- (2009) Yi-Hong Zhou et al. JOURNAL OF NEURO-ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started